Manuka honey microneedle
US-11904125-B2 · Feb 20, 2024 · US
US10232159B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10232159-B2 |
| Application number | US-201515122664-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 2, 2015 |
| Priority date | Mar 4, 2014 |
| Publication date | Mar 19, 2019 |
| Grant date | Mar 19, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention relates to a device for use in skin improvement or repair, including promoting hair growth, comprising the use of microneedles for the transplantation of cells and a method employing the use of same.
Opening claim text (preview).
The invention claimed is: 1. A device for skin improvement or repair comprising: a plurality of microneedles attached to or integral with a supporting base member and arranged in at least one circular pattern on same wherein said microneedles are hollow and have a bore size of between 75-150 μm diameter and a length of between 250 μm and 1000 μm, wherein the device is adapted for (a) extracting cells from a first area of skin of an individual, and subsequently (b) injecting said cells into a second area of skin of said individual, wherein there is no observed loss of viability of said cells as a result of the transplantation process; and whereby said second area of skin is improved by the transplantation of said cells. 2. The device according to claim 1 wherein in step (b), said cells are injected into the viable epidermis, papillary. 3. The device according to claim 1 wherein said microneedles have a bore size of 75-150 μm diameter. 4. The device according to claim 1 wherein a plurality of concentric circular patterns of microneedles is provided on said base member. 5. The device according to claim 4 wherein two concentric circular patterns of microneedles are provided on said base member. 6. The device according to claim 1 wherein said microneedles are attached to or integral with said base member so that their longitudinal axis is normal to the supporting axis of said base member or so that their longitudinal axis is at an angle to the supporting axis of said base member such that said microneedles splay outwards with respect to the supporting axis of said base member. 7. The device according claim 1 wherein between 6 and 48 microneedles are used in each of said circular patterns. 8. The device according to claim 1 wherein 24 microneedles are used in an outer concentric circular pattern and 12 microneedles are used in an inner concentric circular pattern. 9. The device according to claim 1 wherein said microneedles are between 250 μm and 1000 μm in length. 10. The device according to claim 1 wherein said microneedles are about 750 μm in length. 11. The device according to claim 1 wherein said microneedles are made from a polymer, co-polymer, polysaccharide, sugar, silicon or steel. 12. A method for skin improvement or repair comprising: a) extracting with a plurality of microneedles attached to a supporting base member and arranged in at least one circular pattern on same at least one cell from a first area of skin of an individual to be treated; and b) injecting with at least one hollow microneedle, having a bore size of 75-150 μm and a length of between 250 μm and 1000 μm, said cell(s) into a second area of skin; whereby said second area of skin is improved by the transplantation of said cell(s) therein wherein there is no observed loss of viability of said cells as a result of the transplantation process; and whereby said second area of skin is improved by the transplantation of said cells. 13. The method according to claim 12 wherein said bore size is between 75 and 150 μm diameter. 14. The method according to claim 12 wherein said injecting also involves the use of a single microneedle or a plurality of microneedles attached to a supporting base member and where a plurality of microneedles are used they are arranged in at least one row, rectangular array or circular pattern on same. 15. The method according to claim 12 wherein said cell(s) are selected from the group comprising: melanocytes, keratinocytes, dermal fibroblasts, corneocytes, Langerhans cells, dermal dendritic cells, epidermal stem cells, Merkel cells, mast cells, macrophages, T-cells, dermal sheath cells or follicular outer root sheath cells. 16. The method according to claim 12 wherein in step b) said cell(s) are injected into the viable epidermis, papillary dermis or reticular dermis layers of the skin. 17. The method according to claim 12 wherein the microneedles used in step a) are different to that/those used in step b). 18. The method according to claim 12 wherein said method is repeated for all areas of the skin for which repair or improvement is desired. 19. The method according to claim 12 wherein said cell(s) extracted in step a) are preserved prior to the performance of step b). 20. The method according to claim 19 wherein said cell(s) extracted in step a) are preserved prior to the performance of step b) and further, wherein said preserved cell(s) are used for repeated procedures whereby measured amounts of the preserved cells are repeatedly used for the repeated performance of step b). 21. The method of claim 12 wherein no loss of cell viability occurs.
by using microneedles · CPC title
Drug applicators using microneedles · CPC title
Solid microneedles · CPC title
Pointed or sharp biopsy instruments · CPC title
Methods for using microneedles · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.